Inogen Price to Sales Ratio 2012-2024 | INGN
Historical PS ratio values for Inogen (INGN) over the last 10 years. The current P/S ratio for Inogen as of November 20, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Inogen P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-20 | 9.46 | 0.67 | |
| 2024-09-30 | 9.70 | $14.11 | 0.69 |
| 2024-06-30 | 8.13 | $13.98 | 0.58 |
| 2024-03-31 | 8.07 | $13.84 | 0.58 |
| 2023-12-31 | 5.49 | $13.64 | 0.40 |
| 2023-09-30 | 5.22 | $14.22 | 0.37 |
| 2023-06-30 | 11.55 | $15.21 | 0.76 |
| 2023-03-31 | 12.48 | $16.12 | 0.77 |
| 2022-12-31 | 19.71 | $16.52 | 1.19 |
| 2022-09-30 | 24.28 | $16.06 | 1.51 |
| 2022-06-30 | 24.18 | $15.53 | 1.56 |
| 2022-03-31 | 32.42 | $15.44 | 2.10 |
| 2021-12-31 | 34.00 | $15.83 | 2.15 |
| 2021-09-30 | 43.09 | $15.80 | 2.73 |
| 2021-06-30 | 65.17 | $15.10 | 4.31 |
| 2021-03-31 | 52.52 | $13.89 | 3.78 |
| 2020-12-31 | 44.68 | $14.01 | 3.19 |
| 2020-09-30 | 29.00 | $14.19 | 2.04 |
| 2020-06-30 | 35.52 | $14.95 | 2.38 |
| 2020-03-31 | 51.66 | $16.24 | 3.18 |
| 2019-12-31 | 68.33 | $16.21 | 4.22 |
| 2019-09-30 | 47.91 | $16.50 | 2.90 |
| 2019-06-30 | 66.76 | $16.57 | 4.03 |
| 2019-03-31 | 95.37 | $16.37 | 5.83 |
| 2018-12-31 | 124.17 | $15.92 | 7.80 |
| 2018-09-30 | 244.12 | $14.98 | 16.29 |
| 2018-06-30 | 186.33 | $13.92 | 13.39 |
| 2018-03-31 | 122.84 | $12.53 | 9.80 |
| 2017-12-31 | 119.08 | $11.42 | 10.43 |
| 2017-09-30 | 95.10 | $10.92 | 8.71 |
| 2017-06-30 | 95.42 | $10.35 | 9.22 |
| 2017-03-31 | 77.56 | $10.01 | 7.75 |
| 2016-12-31 | 67.17 | $9.64 | 6.97 |
| 2016-09-30 | 59.90 | $9.18 | 6.52 |
| 2016-06-30 | 50.11 | $8.58 | 5.84 |
| 2016-03-31 | 44.98 | $8.11 | 5.55 |
| 2015-12-31 | 40.09 | $7.69 | 5.22 |
| 2015-09-30 | 48.55 | $7.35 | 6.61 |
| 2015-06-30 | 44.60 | $6.84 | 6.52 |
| 2015-03-31 | 31.99 | $6.22 | 5.14 |
| 2014-12-31 | 31.37 | $7.08 | 4.43 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.226B | $0.316B |
| Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $194.739B | 23.76 |
| Intuitive Surgical (ISRG) | United States | $191.917B | 100.34 |
| Alcon (ALC) | Switzerland | $42.138B | 28.19 |
| Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
| IQVIA Holdings (IQV) | United States | $34.726B | 19.13 |
| IDEXX Laboratories (IDXX) | United States | $34.092B | 40.15 |
| DexCom (DXCM) | United States | $29.248B | 44.05 |
| STERIS (STE) | Ireland | $20.926B | 24.09 |
| Waters (WAT) | United States | $20.468B | 30.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
| Hologic (HOLX) | United States | $18.250B | 19.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.969B | 13.31 |
| Sysmex ADR (SSMXY) | Japan | $12.688B | 39.79 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Penumbra (PEN) | United States | $9.100B | 89.14 |
| Teleflex (TFX) | United States | $8.967B | 14.30 |
| Masimo (MASI) | United States | $8.754B | 42.36 |
| Glaukos (GKOS) | United States | $7.951B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.883B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.479B | 25.38 |
| Veracyte (VCYT) | United States | $3.034B | 91.05 |
| Inari Medical (NARI) | United States | $2.984B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.789B | 16.10 |
| TransMedics (TMDX) | United States | $2.783B | 88.21 |
| Nihon Kohden (NHNKY) | Japan | $2.293B | 17.42 |
| Elekta AB (EKTAY) | Sweden | $2.192B | 17.86 |
| Tandem Diabetes Care (TNDM) | United States | $1.830B | 0.00 |
| RxSight (RXST) | United States | $1.819B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.766B | 9.23 |
| Alphatec Holdings (ATEC) | United States | $1.357B | 0.00 |
| Artivion (AORT) | United States | $1.129B | 74.81 |
| OPKO Health (OPK) | United States | $1.106B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| Paragon 28 (FNA) | United States | $0.879B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.818B | 13.91 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.716B | 0.00 |
| IRadimed (IRMD) | United States | $0.650B | 35.10 |
| OrthoPediatrics (KIDS) | United States | $0.589B | 0.00 |
| AxoGen (AXGN) | United States | $0.561B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.542B | 12.77 |
| SiBone (SIBN) | United States | $0.517B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.483B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.471B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.378B | 20.48 |
| Semler Scientific (SMLR) | United States | $0.337B | 22.60 |
| CVRx (CVRX) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.317B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.303B | 0.00 |
| NeuroPace (NPCE) | United States | $0.274B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.273B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.161B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Nevro (NVRO) | United States | $0.159B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.137B | 14.68 |
| Spectral Diagnostics (EDTXF) | Canada | $0.112B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.088B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| 908 Devices (MASS) | United States | $0.086B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.078B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Neuronetics (STIM) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |